Background to and Management of Treatment-Related Bone Loss in Prostate Cancer

ISSN： 1170-229X

Source： Drugs & Aging, Vol.19, Iss.12, 2002-01, pp. : 899-910

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strategies for Management of Prostate Cancer-Related Bone Pain

By Pelger R.C.M.

Drugs & Aging, Vol. 18, Iss. 12, 2001-12 ,pp. : 899-911

Adis International

Access to resources Recommend Favorite

Therapeutic benefit of bisphosphonates in the management of prostate cancer-related bone disease

By Dawson Nancy A

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 705-716

Informa Healthcare

Access to resources Recommend Favorite

Optimal Management of Cancer Treatment-Induced Bone Loss: Considerations for Elderly Patients

By Tipples Karen Robinson Anne

Drugs & Aging, Vol. 28, Iss. 11, 2011-11 ,pp. : 867-883

Adis International

Access to resources Recommend Favorite

Emerging drugs for the management of cancer treatment induced bone loss

By Bertoldo Francesco Pancheri Serena Zenari Sonia Boldini Stefania

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. : 323-342

Informa Healthcare

Access to resources Recommend Favorite

By Qi Wei-Xiang Tang Li-Na Shen Zan Yao Yang

European Journal of Clinical Pharmacology, Vol. 70, Iss. 4, 2014-04 ,pp. : 461-467

Springer Publishing Company

Access to resources Recommend Favorite